<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2893641&amp;fmt=gif">

Barclay Hedge Fund Index Down 0.44% in July; European and US Equities Burden Fund Managers

FAIRFIELD, Iowa, August 20, 2014 — Hedge funds lost 0.44% in July, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index remains up 3.26% in 2014.

“European equity prices dropped due to weakening economic data, and US equity prices dropped based on a strengthening recovery,” says Sol Waksman, founder and president of BarclayHedge.

“It was a difficult month for equity funds hoping to turn a profit.”

Eleven of Barclay’s 18 hedge fund indices had losses in July. The Barclay Healthcare & Biotechnology Index gave up 2.36%, Technology lost 1.66%, Equity Long Bias was down 1.17%, and European Equities lost 1.08%.

On the positive side, the Barclay Pacific Rim Equities Index was up 1.23%, Emerging Markets Index gained 0.82%, and Convertible Arbitrage added 0.24%.

Year to date, the best performing hedge fund strategy is Healthcare & Biotechnology, with an overall 8.70% gain. Equity Short Bias has lost 9.24%, and Technology is down 3.53%.

The Barclay Fund of Funds Index lost 0.46% in July, and but is still up 1.38% in 2014.

Click here to view five years of Barclay Hedge Fund Index data or download 17 years of monthly data.

Sol Waksman is an experienced media source, providing perspectives on hedge fund and managed futures trends. For more commentary or background, call 641-472-3456 or email swaksman@barclayhedge.com.

BarclayHedge was founded in 1985 and actively tracks more than 6,200 hedge funds, funds of hedge funds, and managed futures programs. Each month Barclay provides updated performance rankings for 38 Hedge Fund categories, 16 CTA categories, and 7 UCITS categories.

Institutional investors, brokerage firms, and private banks worldwide utilize BarclayHedge indices as performance benchmarks for the hedge fund and managed futures industries.